A novel epithelial‐mesenchymal transition molecular signature predicts the oncological outcomes in colorectal cancer

Epithelial‐mesenchymal transition (EMT), a biological process involving the transformation of epithelial cells into mesenchymal cells, promotes tumour initiation and metastasis. The aim of this study was to construct an EMT molecular signature for predicting colorectal cancer (CRC) prognosis and eva...

Full description

Saved in:
Bibliographic Details
Published inJournal of cellular and molecular medicine Vol. 25; no. 7; pp. 3194 - 3204
Main Authors Shan, Zezhi, Wu, Wen, Yan, Xuebing, Yang, Yongzhi, Luo, Dakui, Liu, Qi, Li, Xinxiang, Goel, Ajay, Ma, Yanlei
Format Journal Article
LanguageEnglish
Published England John Wiley & Sons, Inc 01.04.2021
John Wiley and Sons Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Epithelial‐mesenchymal transition (EMT), a biological process involving the transformation of epithelial cells into mesenchymal cells, promotes tumour initiation and metastasis. The aim of this study was to construct an EMT molecular signature for predicting colorectal cancer (CRC) prognosis and evaluate the efficacy of the model. The risk scoring system, constructed by log‐rank test and multivariate Cox regression analysis according to EMT‐related gene expression in CRC patients from TCGA database, demonstrated the highest correlation with prognosis compared with other parameters in CRC patients. The risk scores were significantly correlated with more lymph node metastasis, distal metastasis and advanced clinical stage of CRC. The model was further successfully validated in two independent external cohorts from GEO database. Furthermore, we developed a nomogram to integrate the EMT signature with the pathological stage of CRC, which was found to perform well in predicting the overall survival. Additionally, this risk scoring model was found to be associated with immune cell infiltration, implying a potential role of EMT involved in immunity regulation in tumour microenvironment. Taken together, our novel EMT molecular model may be useful in identifying high‐risk patients who need an intensive follow‐up and more aggressive therapy, finally contributing to more precise individualized therapeutic strategies.
AbstractList Epithelial‐mesenchymal transition (EMT), a biological process involving the transformation of epithelial cells into mesenchymal cells, promotes tumour initiation and metastasis. The aim of this study was to construct an EMT molecular signature for predicting colorectal cancer (CRC) prognosis and evaluate the efficacy of the model. The risk scoring system, constructed by log‐rank test and multivariate Cox regression analysis according to EMT‐related gene expression in CRC patients from TCGA database, demonstrated the highest correlation with prognosis compared with other parameters in CRC patients. The risk scores were significantly correlated with more lymph node metastasis, distal metastasis and advanced clinical stage of CRC. The model was further successfully validated in two independent external cohorts from GEO database. Furthermore, we developed a nomogram to integrate the EMT signature with the pathological stage of CRC, which was found to perform well in predicting the overall survival. Additionally, this risk scoring model was found to be associated with immune cell infiltration, implying a potential role of EMT involved in immunity regulation in tumour microenvironment. Taken together, our novel EMT molecular model may be useful in identifying high‐risk patients who need an intensive follow‐up and more aggressive therapy, finally contributing to more precise individualized therapeutic strategies.
Epithelial-mesenchymal transition (EMT), a biological process involving the transformation of epithelial cells into mesenchymal cells, promotes tumour initiation and metastasis. The aim of this study was to construct an EMT molecular signature for predicting colorectal cancer (CRC) prognosis and evaluate the efficacy of the model. The risk scoring system, constructed by log-rank test and multivariate Cox regression analysis according to EMT-related gene expression in CRC patients from TCGA database, demonstrated the highest correlation with prognosis compared with other parameters in CRC patients. The risk scores were significantly correlated with more lymph node metastasis, distal metastasis and advanced clinical stage of CRC. The model was further successfully validated in two independent external cohorts from GEO database. Furthermore, we developed a nomogram to integrate the EMT signature with the pathological stage of CRC, which was found to perform well in predicting the overall survival. Additionally, this risk scoring model was found to be associated with immune cell infiltration, implying a potential role of EMT involved in immunity regulation in tumour microenvironment. Taken together, our novel EMT molecular model may be useful in identifying high-risk patients who need an intensive follow-up and more aggressive therapy, finally contributing to more precise individualized therapeutic strategies.Epithelial-mesenchymal transition (EMT), a biological process involving the transformation of epithelial cells into mesenchymal cells, promotes tumour initiation and metastasis. The aim of this study was to construct an EMT molecular signature for predicting colorectal cancer (CRC) prognosis and evaluate the efficacy of the model. The risk scoring system, constructed by log-rank test and multivariate Cox regression analysis according to EMT-related gene expression in CRC patients from TCGA database, demonstrated the highest correlation with prognosis compared with other parameters in CRC patients. The risk scores were significantly correlated with more lymph node metastasis, distal metastasis and advanced clinical stage of CRC. The model was further successfully validated in two independent external cohorts from GEO database. Furthermore, we developed a nomogram to integrate the EMT signature with the pathological stage of CRC, which was found to perform well in predicting the overall survival. Additionally, this risk scoring model was found to be associated with immune cell infiltration, implying a potential role of EMT involved in immunity regulation in tumour microenvironment. Taken together, our novel EMT molecular model may be useful in identifying high-risk patients who need an intensive follow-up and more aggressive therapy, finally contributing to more precise individualized therapeutic strategies.
Author Li, Xinxiang
Yan, Xuebing
Shan, Zezhi
Luo, Dakui
Ma, Yanlei
Yang, Yongzhi
Goel, Ajay
Wu, Wen
Liu, Qi
AuthorAffiliation 1 Department of Colorectal Surgery Fudan University Shanghai Cancer Center Shanghai China
4 Department of Oncology the Affiliated Hospital of Yangzhou University Yangzhou University Yangzhou China
5 Department of Molecular Diagnostics and Experimental Therapeutics Beckman Research Institute of City of Hope Comprehensive Cancer Center Duarte CA USA
2 Department of Oncology Shanghai Medical College Fudan University Shanghai China
3 Department of Surgery Shanghai Pudong Hospital (Fudan University Pudong Medical Center) Shanghai China
AuthorAffiliation_xml – name: 4 Department of Oncology the Affiliated Hospital of Yangzhou University Yangzhou University Yangzhou China
– name: 3 Department of Surgery Shanghai Pudong Hospital (Fudan University Pudong Medical Center) Shanghai China
– name: 2 Department of Oncology Shanghai Medical College Fudan University Shanghai China
– name: 5 Department of Molecular Diagnostics and Experimental Therapeutics Beckman Research Institute of City of Hope Comprehensive Cancer Center Duarte CA USA
– name: 1 Department of Colorectal Surgery Fudan University Shanghai Cancer Center Shanghai China
Author_xml – sequence: 1
  givenname: Zezhi
  surname: Shan
  fullname: Shan, Zezhi
  organization: Fudan University
– sequence: 2
  givenname: Wen
  surname: Wu
  fullname: Wu, Wen
  organization: Shanghai Pudong Hospital (Fudan University Pudong Medical Center)
– sequence: 3
  givenname: Xuebing
  surname: Yan
  fullname: Yan, Xuebing
  organization: Yangzhou University
– sequence: 4
  givenname: Yongzhi
  surname: Yang
  fullname: Yang, Yongzhi
  organization: Fudan University
– sequence: 5
  givenname: Dakui
  surname: Luo
  fullname: Luo, Dakui
  organization: Fudan University
– sequence: 6
  givenname: Qi
  orcidid: 0000-0002-7121-8563
  surname: Liu
  fullname: Liu, Qi
  organization: Fudan University
– sequence: 7
  givenname: Xinxiang
  surname: Li
  fullname: Li, Xinxiang
  email: yanleima@fudan.edu.cn, 1149lxx@sina.com, ajgoel@coh.org
  organization: Fudan University
– sequence: 8
  givenname: Ajay
  surname: Goel
  fullname: Goel, Ajay
  email: ajgoel@coh.org
  organization: Beckman Research Institute of City of Hope Comprehensive Cancer Center
– sequence: 9
  givenname: Yanlei
  orcidid: 0000-0002-0632-5258
  surname: Ma
  fullname: Ma, Yanlei
  email: yanleima@fudan.edu.cn
  organization: Fudan University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33660944$$D View this record in MEDLINE/PubMed
BookMark eNp9ks1uEzEQxy1URD_gwgMgS1wQUoq99vrjglRFfKoVFzhbrnc2ceS1g72bKjcegWfkSXCaUEGF6out8e__nxnNnKKjmCIg9JySc1rPm5UbhnMqmJKP0AltVTPjmvGjw5sqpo7RaSkrQpigTD9Bx4wJQTTnJ2hzgWPaQMCw9uMSgrfh14-fAxSIbrkdbMBjtrH40aeIhxTATcFmXPwi2nHKgNcZOu_Ggqsap-hSSAvvqi5No0vVCPuId9EMbqxhZ6OD_BQ97m0o8Oxwn6Fv7999nX-cXX758Gl-cTlzXAo5U6KTkvWWKcZp32plBelUC9CBJJz0UjrWd5Twa961jiuiBbXU6o66TreMsjP0du-7nq4H6BzE2k4w6-wHm7cmWW_-_Yl-aRZpYxRhnLeyGrw6GOT0fYIymsEXByHYCGkqpuFaEi1Zs8v18h66SlOOtT3TCMlZS3mjH6RaShpB2G3aF3_XfVfwn8FV4PUecDmVkqG_Qygxu60wu60wt1tRYXIPdn60u5HWnn34v4TuJTc-wPYBc_N5fnW11_wGGNPM1A
CitedBy_id crossref_primary_10_1002_cam4_5384
crossref_primary_10_1186_s12876_022_02257_2
crossref_primary_10_18632_aging_204878
crossref_primary_10_18632_aging_205946
crossref_primary_10_1002_cam4_4568
crossref_primary_10_1007_s00432_022_04070_6
crossref_primary_10_1016_j_compbiomed_2023_106639
crossref_primary_10_1155_2023_5093941
Cites_doi 10.1200/JCO.18.02258
10.1002/advs.201901380
10.3389/fonc.2020.00183
10.3322/caac.21551
10.1016/j.stem.2010.04.001
10.1038/s41568-019-0168-y
10.1038/s41580-018-0080-4
10.1038/nm.3967
10.3727/096504016X14685034103554
10.18632/oncotarget.13116
10.1200/JCO.2011.36.5080
10.1038/s41580-020-0237-9
10.1136/gutjnl-2018-316324
10.1016/j.ccell.2018.09.003
10.1016/j.ccr.2013.08.005
10.1158/0008-5472.CAN-14-0923
10.1053/j.gastro.2018.11.019
10.1038/nrclinonc.2017.44
10.1038/emboj.2010.351
10.3109/03009734.2011.638729
10.1038/nrc1740
10.1007/s00401-017-1757-z
10.1016/j.jgg.2019.11.010
10.1038/s41586-020-2394-6
10.18632/aging.102776
10.1016/j.jhep.2020.05.004
10.1038/nature16064
10.3390/genes5030536
10.1038/ncb3513
10.1016/j.bbrc.2016.11.126
10.1016/j.cell.2008.03.027
10.1038/s41568-019-0213-x
10.1073/pnas.1618091114
10.1007/s00384-012-1520-9
ContentType Journal Article
Copyright 2021 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.
2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.
2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2021 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.
– notice: 2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.
– notice: 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
NPM
3V.
7QP
7TK
7X7
7XB
88E
88I
8AO
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
P64
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
RC3
7X8
5PM
DOI 10.1111/jcmm.16387
DatabaseName Wiley-Blackwell Open Access Titles
CrossRef
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni Edition)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
Health & Medical Collection (Alumni Edition)
Medical Database
Science Database
Biological Science Database
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest Central Student
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Genetics Abstracts
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database
Publicly Available Content Database
MEDLINE - Academic


PubMed
CrossRef
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate SHAN et al
EISSN 1582-4934
EndPage 3204
ExternalDocumentID PMC8034457
33660944
10_1111_jcmm_16387
JCMM16387
Genre article
Journal Article
GrantInformation_xml – fundername: National Ten Thousand Plan Young Top Talents
– fundername: Fudan University Excellence 2025 Talent Cultivation Plan
– fundername: Shanghai Science and Technology Development Fund
  funderid: 19410713300; 20XD1421200
– fundername: CSCO‐Roche Tumor Research Fund
  funderid: Y‐2019Roche‐079
– fundername: Shanghai Young Top Talents
  funderid: QNBJ1701
– fundername: National Natural Science Foundation of China
  funderid: 81920108026; 81871964
– fundername: Shanghai Young Top Talents
  grantid: QNBJ1701
– fundername: National Natural Science Foundation of China
  grantid: 81920108026
– fundername: National Natural Science Foundation of China
  grantid: 81871964
– fundername: Shanghai Science and Technology Development Fund
  grantid: 19410713300
– fundername: CSCO-Roche Tumor Research Fund
  grantid: Y-2019Roche-079
– fundername: Shanghai Science and Technology Development Fund
  grantid: 20XD1421200
– fundername: National Natural Science Foundation of China
  grantid: 81920108026; 81871964
– fundername: CSCO‐Roche Tumor Research Fund
  grantid: Y‐2019Roche‐079
– fundername: ;
  grantid: 19410713300; 20XD1421200
GroupedDBID ---
0R~
1OC
24P
29K
31~
36B
3V.
4.4
53G
5GY
5VS
7X7
8-0
8-1
88E
88I
8AO
8FE
8FH
8FI
8FJ
8R4
8R5
AAHHS
AAZKR
ABUWG
ACCFJ
ACCMX
ACGFS
ACGOD
ACXQS
ADBBV
ADKYN
ADPDF
ADRAZ
ADZMN
ADZOD
AEEZP
AENEX
AEQDE
AFBPY
AFKRA
AFZJQ
AHMBA
AIWBW
AJBDE
ALAGY
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AOIJS
AVUZU
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
D-9
D-I
DIK
DU5
DWQXO
E3Z
EBD
EBS
EJD
EMB
EMOBN
F5P
FYUFA
GNUQQ
GODZA
GROUPED_DOAJ
HCIFZ
HMCUK
HYE
HZ~
IAO
IHR
ITC
KQ8
LH4
LK8
LW6
M1P
M2P
M48
M7P
O9-
OIG
OK1
OVD
OVEED
PIMPY
PQQKQ
PROAC
PSQYO
Q2X
RNS
ROL
RPM
SV3
TEORI
UKHRP
WIN
AAYXX
ABJNI
CITATION
PHGZM
PHGZT
NPM
7QP
7TK
7XB
8FD
8FK
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
FR3
K9.
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
Q9U
RC3
7X8
5PM
ID FETCH-LOGICAL-c4767-86d773fa38341f598a60d85eede7040f77c3fd104b4d5c480961a1a9d1cd95313
IEDL.DBID M48
ISSN 1582-1838
1582-4934
IngestDate Thu Aug 21 14:04:55 EDT 2025
Fri Jul 11 00:57:31 EDT 2025
Wed Aug 13 09:51:13 EDT 2025
Wed Aug 13 07:31:45 EDT 2025
Wed Feb 19 02:27:47 EST 2025
Tue Jul 01 01:35:15 EDT 2025
Thu Apr 24 23:06:17 EDT 2025
Wed Jan 22 16:29:49 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords colorectal cancer
immunity
risk score model
prognosis
epithelial-Mesenchymal Transition
Language English
License Attribution
2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.
This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4767-86d773fa38341f598a60d85eede7040f77c3fd104b4d5c480961a1a9d1cd95313
Notes Zezhi Shan, Wen Wu, Xuebing Yan and Yongzhi Yang contributed equally to this work.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-7121-8563
0000-0002-0632-5258
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1111/jcmm.16387
PMID 33660944
PQID 2510260357
PQPubID 2034150
PageCount 11
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8034457
proquest_miscellaneous_2497097321
proquest_journals_2674351429
proquest_journals_2510260357
pubmed_primary_33660944
crossref_primary_10_1111_jcmm_16387
crossref_citationtrail_10_1111_jcmm_16387
wiley_primary_10_1111_jcmm_16387_JCMM16387
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate April 2021
PublicationDateYYYYMMDD 2021-04-01
PublicationDate_xml – month: 04
  year: 2021
  text: April 2021
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Chichester
– name: Hoboken
PublicationTitle Journal of cellular and molecular medicine
PublicationTitleAlternate J Cell Mol Med
PublicationYear 2021
Publisher John Wiley & Sons, Inc
John Wiley and Sons Inc
Publisher_xml – name: John Wiley & Sons, Inc
– name: John Wiley and Sons Inc
References 2013; 28
2013; 24
2020; 583
2019; 37
2011; 30
2019; 19
2015; 527
2020; 12
2020; 10
2017; 134
2017; 114
2020; 7
2016; 7
2014; 5
2019; 20
2017; 14
2020; 73
2019; 46
2019; 68
2019; 69
2015; 21
2005; 5
2017; 19
2017; 482
2020; 21
2014; 74
2018; 34
2008; 133
2011; 29
2012; 117
2010; 6
2016; 24
2019; 156
e_1_2_9_30_1
e_1_2_9_31_1
e_1_2_9_11_1
e_1_2_9_34_1
e_1_2_9_10_1
e_1_2_9_35_1
e_1_2_9_13_1
e_1_2_9_32_1
e_1_2_9_12_1
e_1_2_9_33_1
Cheng M (e_1_2_9_23_1) 2020; 10
e_1_2_9_15_1
e_1_2_9_14_1
e_1_2_9_17_1
e_1_2_9_36_1
e_1_2_9_16_1
e_1_2_9_37_1
e_1_2_9_19_1
e_1_2_9_18_1
e_1_2_9_20_1
e_1_2_9_22_1
e_1_2_9_21_1
e_1_2_9_24_1
e_1_2_9_8_1
e_1_2_9_7_1
e_1_2_9_6_1
e_1_2_9_5_1
e_1_2_9_4_1
e_1_2_9_3_1
e_1_2_9_2_1
e_1_2_9_9_1
e_1_2_9_26_1
e_1_2_9_25_1
e_1_2_9_28_1
e_1_2_9_27_1
e_1_2_9_29_1
References_xml – volume: 69
  start-page: 7
  issue: 1
  year: 2019
  end-page: 34
  article-title: Cancer statistics, 2019
  publication-title: CA Cancer J Clin
– volume: 30
  start-page: 783
  issue: 4
  year: 2011
  end-page: 795
  article-title: TGF‐β regulates isoform switching of FGF receptors and epithelial‐mesenchymal transition
  publication-title: EMBO J
– volume: 527
  start-page: 525
  issue: 7579
  year: 2015
  end-page: 530
  article-title: Epithelial‐to‐mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
  publication-title: Nature
– volume: 7
  start-page: 1901380
  issue: 3
  year: 2020
  article-title: Targeting YAP1/LINC00152/FSCN1 Signaling Axis Prevents the Progression of Colorectal Cancer
  publication-title: Adv Sci (Weinh)
– volume: 74
  start-page: 6330
  issue: 21
  year: 2014
  end-page: 6340
  article-title: Transient SNAIL1 expression is necessary for metastatic competence in breast cancer
  publication-title: Can Res
– volume: 19
  start-page: 454
  issue: 8
  year: 2019
  end-page: 464
  article-title: YAP and TAZ: a signalling hub of the tumour microenvironment
  publication-title: Nat Rev Cancer
– volume: 20
  start-page: 69
  issue: 2
  year: 2019
  end-page: 84
  article-title: New insights into the mechanisms of epithelial‐mesenchymal transition and implications for cancer
  publication-title: Nat Rev Mol Cell Biol
– volume: 21
  start-page: 1350
  issue: 11
  year: 2015
  end-page: 1356
  article-title: The consensus molecular subtypes of colorectal cancer
  publication-title: Nat Med
– volume: 6
  start-page: 603
  issue: 6
  year: 2010
  end-page: 615
  article-title: A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer
  publication-title: Cell Stem Cell
– volume: 134
  start-page: 923
  issue: 6
  year: 2017
  end-page: 940
  article-title: RNAi screen identifies essential regulators of human brain metastasis‐initiating cells
  publication-title: Acta Neuropathol
– volume: 46
  start-page: 595
  issue: 12
  year: 2019
  end-page: 597
  article-title: dbEMT 2.0: An updated database for epithelial‐mesenchymal transition genes with experimentally verified information and precalculated regulation information for cancer metastasis
  publication-title: J Genet Genomics
– volume: 24
  start-page: 347
  issue: 3
  year: 2013
  end-page: 364
  article-title: Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cells
  publication-title: Cancer Cell
– volume: 12
  start-page: 2777
  issue: 3
  year: 2020
  end-page: 2797
  article-title: TP53/miR‐34a‐associated signaling targets expression in human pancreatic cancer
  publication-title: Aging (Albany NY)
– volume: 29
  start-page: 4796
  issue: 36
  year: 2011
  end-page: 4802
  article-title: Predicting survival after curative colectomy for cancer: individualizing colon cancer staging
  publication-title: J Clin Oncol
– volume: 5
  start-page: 536
  issue: 3
  year: 2014
  end-page: 560
  article-title: From genotype to functional phenotype: unraveling the metabolomic features of colorectal cancer
  publication-title: Genes (Basel)
– volume: 24
  start-page: 437
  issue: 6
  year: 2016
  end-page: 445
  article-title: Knockdown of SPOCK1 Inhibits the Proliferation and Invasion in Colorectal Cancer Cells by Suppressing the PI3K/Akt Pathway
  publication-title: Oncol Res
– volume: 19
  start-page: 518
  issue: 5
  year: 2017
  end-page: 529
  article-title: The EMT‐activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer
  publication-title: Nat Cell Biol
– volume: 68
  start-page: 1764
  issue: 10
  year: 2019
  end-page: 1773
  article-title: Tumour‐associated macrophages‐derived CXCL8 determines immune evasion through autonomous PD‐L1 expression in gastric cancer
  publication-title: Gut
– volume: 34
  start-page: 561
  issue: 4
  year: 2018
  end-page: 578.e6
  article-title: Complement C5a fosters squamous carcinogenesis and limits T cell response to chemotherapy
  publication-title: Cancer Cell
– volume: 14
  start-page: 611
  issue: 10
  year: 2017
  end-page: 629
  article-title: EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
  publication-title: Nat Rev Clin Oncol
– volume: 10
  start-page: 183
  year: 2020
  article-title: Genomics and prognosis analysis of epithelial‐mesenchymal transition in glioma
  publication-title: Front Oncol
– volume: 5
  start-page: 899
  issue: 11
  year: 2005
  end-page: 904
  article-title: Opinion: the origin of the cancer stem cell: current controversies and new insights
  publication-title: Nat Rev Cancer
– volume: 28
  start-page: 9
  issue: 1
  year: 2013
  end-page: 18
  article-title: CD44v6, c‐Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk
  publication-title: Int J Colorectal Dis
– volume: 21
  start-page: 341
  issue: 6
  year: 2020
  end-page: 352
  article-title: Guidelines and definitions for research on epithelial‐mesenchymal transition
  publication-title: Nat Rev Mol Cell Biol
– volume: 117
  start-page: 143
  issue: 2
  year: 2012
  end-page: 152
  article-title: Tumor‐promoting functions of transforming growth factor‐β in progression of cancer
  publication-title: Ups J Med Sci
– volume: 156
  issue: 4
  year: 2019
  article-title: NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice
  publication-title: Gastroenterology
– volume: 37
  start-page: 1876
  issue: 22
  year: 2019
  end-page: 1885
  article-title: Impact of Consensus Molecular Subtype on Survival in Patients With Metastatic Colorectal Cancer: Results From CALGB/SWOG 80405 (Alliance)
  publication-title: J Clin Oncol
– volume: 19
  start-page: 716
  issue: 12
  year: 2019
  end-page: 732
  article-title: Controversies around epithelial‐mesenchymal plasticity in cancer metastasis
  publication-title: Nat Rev Cancer
– volume: 583
  start-page: 133
  issue: 7814
  year: 2020
  end-page: 138
  article-title: DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25
  publication-title: Nature
– volume: 482
  start-page: 870
  issue: 4
  year: 2017
  end-page: 876
  article-title: SPOCK1 is up‐regulated and promotes tumor growth via the PI3K/AKT signaling pathway in colorectal cancer
  publication-title: Biochem Biophys Res Comm
– volume: 114
  start-page: 11494
  issue: 43
  year: 2017
  end-page: 11499
  article-title: Breast tumor cell‐specific knockout of inhibits cancer cell plasticity, dissemination, and lung metastasis in mice
  publication-title: Proc Natl Acad Sci USA
– volume: 7
  start-page: 85021
  issue: 51
  year: 2016
  end-page: 85032
  article-title: EGF induces epithelial‐mesenchymal transition through phospho‐Smad2/3‐Snail signaling pathway in breast cancer cells
  publication-title: Oncotarget
– volume: 10
  start-page: 403
  issue: 2
  year: 2020
  end-page: 423
  article-title: FLNA promotes chemoresistance of colorectal cancer through inducing epithelial‐mesenchymal transition and smad2 signaling pathway
  publication-title: Am J Cancer Res
– volume: 73
  start-page: 906
  issue: 4
  year: 2020
  end-page: 917
  article-title: Glycolytic activation of monocytes regulates the accumulation and function of neutrophils in human hepatocellular carcinoma
  publication-title: J Hepatol
– volume: 133
  start-page: 704
  issue: 4
  year: 2008
  end-page: 715
  article-title: The epithelial‐mesenchymal transition generates cells with properties of stem cells
  publication-title: Cell
– ident: e_1_2_9_15_1
  doi: 10.1200/JCO.18.02258
– volume: 10
  start-page: 403
  issue: 2
  year: 2020
  ident: e_1_2_9_23_1
  article-title: FLNA promotes chemoresistance of colorectal cancer through inducing epithelial‐mesenchymal transition and smad2 signaling pathway
  publication-title: Am J Cancer Res
– ident: e_1_2_9_25_1
  doi: 10.1002/advs.201901380
– ident: e_1_2_9_31_1
  doi: 10.3389/fonc.2020.00183
– ident: e_1_2_9_2_1
  doi: 10.3322/caac.21551
– ident: e_1_2_9_20_1
  doi: 10.1016/j.stem.2010.04.001
– ident: e_1_2_9_37_1
  doi: 10.1038/s41568-019-0168-y
– ident: e_1_2_9_9_1
  doi: 10.1038/s41580-018-0080-4
– ident: e_1_2_9_14_1
  doi: 10.1038/nm.3967
– ident: e_1_2_9_26_1
  doi: 10.3727/096504016X14685034103554
– ident: e_1_2_9_5_1
  doi: 10.18632/oncotarget.13116
– ident: e_1_2_9_3_1
  doi: 10.1200/JCO.2011.36.5080
– ident: e_1_2_9_4_1
  doi: 10.1038/s41580-020-0237-9
– ident: e_1_2_9_32_1
  doi: 10.1136/gutjnl-2018-316324
– ident: e_1_2_9_33_1
  doi: 10.1016/j.ccell.2018.09.003
– ident: e_1_2_9_6_1
  doi: 10.1016/j.ccr.2013.08.005
– ident: e_1_2_9_35_1
– ident: e_1_2_9_13_1
  doi: 10.1158/0008-5472.CAN-14-0923
– ident: e_1_2_9_29_1
  doi: 10.1053/j.gastro.2018.11.019
– ident: e_1_2_9_22_1
  doi: 10.1038/nrclinonc.2017.44
– ident: e_1_2_9_7_1
  doi: 10.1038/emboj.2010.351
– ident: e_1_2_9_8_1
  doi: 10.3109/03009734.2011.638729
– ident: e_1_2_9_18_1
  doi: 10.1038/nrc1740
– ident: e_1_2_9_30_1
  doi: 10.1007/s00401-017-1757-z
– ident: e_1_2_9_16_1
  doi: 10.1016/j.jgg.2019.11.010
– ident: e_1_2_9_34_1
  doi: 10.1038/s41586-020-2394-6
– ident: e_1_2_9_28_1
  doi: 10.18632/aging.102776
– ident: e_1_2_9_36_1
  doi: 10.1016/j.jhep.2020.05.004
– ident: e_1_2_9_12_1
  doi: 10.1038/nature16064
– ident: e_1_2_9_17_1
  doi: 10.3390/genes5030536
– ident: e_1_2_9_11_1
  doi: 10.1038/ncb3513
– ident: e_1_2_9_27_1
  doi: 10.1016/j.bbrc.2016.11.126
– ident: e_1_2_9_19_1
  doi: 10.1016/j.cell.2008.03.027
– ident: e_1_2_9_21_1
  doi: 10.1038/s41568-019-0213-x
– ident: e_1_2_9_10_1
  doi: 10.1073/pnas.1618091114
– ident: e_1_2_9_24_1
  doi: 10.1007/s00384-012-1520-9
SSID ssj0036139
Score 2.3593915
Snippet Epithelial‐mesenchymal transition (EMT), a biological process involving the transformation of epithelial cells into mesenchymal cells, promotes tumour...
Epithelial-mesenchymal transition (EMT), a biological process involving the transformation of epithelial cells into mesenchymal cells, promotes tumour...
SourceID pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 3194
SubjectTerms Clustering
Colorectal cancer
Colorectal carcinoma
Epithelial cells
epithelial‐Mesenchymal Transition
Gene expression
Growth factors
immunity
Lymph nodes
Medical prognosis
Mesenchyme
Metastases
Metastasis
Microenvironments
Multivariate analysis
Nomograms
Original
Patients
Principal components analysis
Prognosis
Regression analysis
risk score model
Software
Statistical analysis
Transcription factors
Tumor microenvironment
Tumors
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1fS-QwEB9OjwNfxDvvtOodOfTlDnpubdokTyJyIsL6pLBvJU1SFLbtutsVfPMj-Bnvk9xMtq0uim8lmUCamcyfZPIbgAOnhLFC8xCNTRFyR9UApeXhwKpUFjqPDaeHwsPL9PyaX4ySUXvgNmvTKjud6BW1rQ2dkR-iHSb4qzgRx5O7kKpG0e1qW0JjBT4SdBmldIlRH3DFaKpUC0nqs3dMWf4h_0MsG6FXnuXrBMmXjqu3PGcbsN66jOxkwePP8MFVX-DToojkwybcn7Cqvndj5ib0vmKMAvXv8amkV0Xm5qHEkQ3ZI5-axcquGi6jxA0P6skmU7qsaWYMR7O6Mp06ZPW8wbVxM3ZbMWol5YjNhgRl-hWuz_5enZ6HbTWF0HCB2lCmVoi40BiS8qhIlNTpwMoEbaQTuJMLIUxcWIzOcm4TwyXVgtGRVjYyVuFOjb_BalVXbhuYtFIlWnFTqAG3OlW49Bhii9xxFeVWB_CrW97MtFDjVPFinPUhB7Ii86wIYL-nnSwANt6k2uu4lLWbbJY9i8Tb3fS-Av3BIxXAz74bdw9diejK1XOk4Up4wKIogK0Fz_tZxHGaYvDLAxBL0tATEDL3ck91e-MRuiUBKdK0fnu5eefHsovT4dB_7bz_i7uwdkTpND5paA9Wm-ncfUd_qMl_eKH_D44IDzg
  priority: 102
  providerName: ProQuest
– databaseName: Wiley-Blackwell Open Access Titles
  dbid: 24P
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1fS9xAEB-sIvSltGrbVFtW9EUh5XLZZHehLyIVEU58UPAtbHY3KFyS4y4n-NaP0M_YT-LM5g8e2kLfQnYWkp3_ycxvAA6dEsYKzUN0NkXIHU0DlJaHI6tSWeg8NpwahSeX6fkNv7hNbtfgR98L0-JDDB_cSDO8vSYF1_niuZKbsvxO0YR4AxvUW0vI-WN-1dvhGB2V8mipGEOi4MoOnNTX8Qx7V93RixjzZank8xDW-6Cz9_CuCx7ZScvtD7Dmqi3YbMdJPm7Dwwmr6gc3ZW5GnRZTFK0_v36X1F9k7h5L3NmQZ_JFWqzs5-IyKuHw8J5sNqffNs2C4W5WV6Y3jKxeNng8bsHuK0Z3yUzibUMiM9-Bm7Of16fnYTdXITRcoF2UqRUiLjQmpzwqEiV1OrIyQW_pBOp0IYSJC4t5Ws5tYrikqTA60spGxirU2fgjrFd15T4Dk1aqRCtuCjXiVqdKJRKTbZE7rqLc6gCO-uPNTAc6TrMvptmQfCArMs-KAA4G2lkLtfEq1V7PpaxTt0WGQRpho8XJX5ap0wIjw7EKYH9YRj2inyO6cvUSabgSHrooCuBTy_PhKeI4TTEN5gGIFWkYCAije3Wlur_zWN2SIBXpsY693PzjxbKL08nEX335H-JdeDumMhtfTLQH68186b5inNTk37w6PAFDDhJn
  priority: 102
  providerName: Wiley-Blackwell
Title A novel epithelial‐mesenchymal transition molecular signature predicts the oncological outcomes in colorectal cancer
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjcmm.16387
https://www.ncbi.nlm.nih.gov/pubmed/33660944
https://www.proquest.com/docview/2510260357
https://www.proquest.com/docview/2674351429
https://www.proquest.com/docview/2497097321
https://pubmed.ncbi.nlm.nih.gov/PMC8034457
Volume 25
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1fi9QwEB_uD4Iv4n-r5xLRF4Ue223aJA8i63HHcbDHIVYWX0qbpNzBtl13u4f75kfwM_pJnMm2xeVO8aUtTQJpZiYz08z8BuCNVUIbkXEflU3hc0vVAKXh_tCoWBZZHmpOicKT8_g04WfTaLoDXf3OdgGXt7p2VE8qWcwOv39bf0CBf99H5eiyPCS7QuzCPmokQQI64f1pQogqSzncVLQmkYVlC1O6PXZbMd2wNm8GTf5pzDptdHIf7rVmJBtv6P4Admz1EO5sCkuuH8H1mFX1tZ0xO6ecixky2a8fP0vKNNKX6xJHNqSjXLgWK7sKuYyCORzQJ5sv6ACnWTIczepKd1skq1cN8qhdsquK0VvaMPG1JuZZPIbk5Pjz0anfVljwNRe4Q8rYCBEWGbqpPCgiJbN4aGSEetMKlO5CCB0WBj22nJtIc0n1YbIgUybQRqH0hk9gr6or-wyYNFJFmeK6UENuslipSKLbLXLLVZCbzIO33fKmuoUfpyoYs7R3Q5AUqSOFB6_7vvMN6MatvQ46KqUd36RorhFKWhj9pZlyLtBGHCkPXvXNKFF0TJJVtl5hH66EAzEKPHi6oXk_izCMY3SIuQdiixv6DoTWvd1SXV061G5J4Io0rXeOb_7xYenZ0WTinp7_10K8gLsjirSheCJxAHvNYmVfoqnU5APYHfELvIqpGMD--EvyNcH7x-Pzi08D9_th4CTlNybJG9I
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VVAguiDeGAouAA0iGOF57vQeESmmVPhIh1Eq9GXt3rVaK7ZA4RbnxE_gl_Ch-CTPrB0SteuvN8q4t2_PtPLwz3wC8MlIoLRLuorHJXG6oG2CkudvXMoyyJPUVp0Lh0TgcHvG94-B4DX63tTCUVtnqRKuodanoH_l7tMNEf-UH4uP0u0tdo2h3tW2hUcNi3yx_YMg2_7D7GeX7ejDY2T7cGrpNVwFXcYFaIQq1EH6WYGjGvSyQURL2dRSgrTACEZ0JofxMY5SSch0oHlFPlMRLpPaUlohYH-97Dda5j6FMD9Y_bY-_fG11v4_GUTYkqDZfSOX5O_J4xKrZO-fLnk_J_N9VtrZu5zbcapxUtlmj6g6smeIuXK_bVi7vwdkmK8ozM2FmShUdE4Twn5-_cqpjUifLHK-syALaZDCWt_13GaWKWBpRNp3R9lA1Z3g1KwvVKmBWLiqUhpmz04LRWVLHeFoRNGf34ehKvvQD6BVlYR4Bi3Qkg0Rylck-10koZRBhUC9Sw6WX6sSBN-3njVVDbk49NiZxF-SgKGIrCgdednOnNaXHhbM2WinFzbKex_9AePEwVXSgBzqQDrzohnG90iZMUphygXO4FJYiyXPgYS3z7il8Pwwx3OYOiBU0dBOIC3x1pDg9sZzgEVE30mO9tbi55MXiva3RyB49vvwVn8ON4eHoID7YHe8_gZsDSuaxKUsb0KtmC_MUvbEqfdYsAQbfrnrV_QW8lkwj
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Jb9QwFH4qRaBeEDuBAkbAAaTAZOLE8QGhqmXUhak4UGluqWM7aqVJMp2laG78BH4PP4dfwnvOAqNWvfUWxU4U-31vi98C8MZKoY1Q3Edlk_vcUjfAxHC_Z2Sc5CoLNadE4eFhvHvE90fRaA1-t7kwFFbZykQnqE2l6R_5R9TDVP4qRAc-b8Iivu0MPk_OfOogRSetbTuNGiIHdvkD3bfZp70dpPXbfn_w5fv2rt90GPA1FyghktgIEeYK3TQe5JFMVNwzSYR6wwpEdy6EDnODHkvGTaR5Qv1RVKCkCbSRiN4Q33sDboowCojHxKhz9kJUk7Iph-oih3RRfCDbR6wqwAtW7cXgzP-NZqf1BnfhTmOusq0aX_dgzZb34VbdwHL5AM63WFmd2zGzE8rtGCOY__z8VVBGkz5ZFvjknHShCwtjRduJl1HQiCsoyiZTOiiazxg-zapSt6KYVYs50sXO2GnJ6C4JZrytCaTTh3B0Lfv8CNbLqrRPgCUmkZGSXOeyx42KpYwSdO9FZrkMMqM8eNdub6qbMufUbWOcdu4OkiJ1pPDgdTd3Uhf3uHTWZkultGHwWfoPjpcPU24H2qJ96cGrbhg5l45jVGmrBc7hUrhiSYEHj2uad18RhnGMjjf3QKygoZtAVcFXR8rTE1cdPKEijvRZ7x1urlhYur89HLqrp1cv8SXcRl5Lv-4dHjyDjT5F9bjYpU1Yn08X9jmaZfPshcM_g-PrZri_TrZO8w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+novel+epithelial%E2%80%90mesenchymal+transition+molecular+signature+predicts+the+oncological+outcomes+in+colorectal+cancer&rft.jtitle=Journal+of+cellular+and+molecular+medicine&rft.au=Shan%2C+Zezhi&rft.au=Wu%2C+Wen&rft.au=Yan%2C+Xuebing&rft.au=Yang%2C+Yongzhi&rft.date=2021-04-01&rft.issn=1582-1838&rft.eissn=1582-4934&rft.volume=25&rft.issue=7&rft.spage=3194&rft.epage=3204&rft_id=info:doi/10.1111%2Fjcmm.16387&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_jcmm_16387
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1582-1838&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1582-1838&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1582-1838&client=summon